The Future Looks Brighter After 25 Years of Retinal Gene Therapy. (2017)
Attributed to:
Development of an AAV vector for treatment of inherited retinal dystrophy caused by RPE65 deficiency
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1089/hum.2017.164
PubMed Identifier: 28825330
Publication URI: http://europepmc.org/abstract/MED/28825330
Type: Journal Article/Review
Volume: 28
Parent Publication: Human gene therapy
Issue: 11
ISSN: 1043-0342